Profound Medical 株価情報 (NASDAQ: PROF)

最新ニュース Profound Medical (NASDAQ:PROF) 株価情報

Profound Medical

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Profound Medical Corp

PROFIRE ENERGY INC COM

ProFrac Holding Corp. - Class A Common Stock

ProFrac Holding Corp

ProFrac Holding Corp Warrants (09/11/2023)

Professional Diversity Network, Inc. - Common Stock

Professional Diversity Network Inc

Professionally Managed Portfolios Congress Intermediate Bond ETF

Professionally Managed Portfolios Congress Large Cap Growth ETF

Professionally Managed Portfolios Congress SMid Growth ETF

Professionally Managed Portfolios Otter Creek Focus Strategy ETF

Proficient Auto Logistics, Inc. - Common Stock

Proficient Auto Logistics Inc

PROFILE SOLUTIONS INC by Profile Solutions, Inc.

Profile Solutions Inc

PROFIT PLANNERS MGMT NEW by Profit Planners Management, Inc.

Profit Planners Management Inc

PROFITABLE DEVELOPMENTS by Profitable Developments, Inc.

Profitable Developments Inc

News

Legal

Press Releases

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

Profound Medical AUA 2025 Investor Event Agenda

Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Profound Medical Corp. - PROF

Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

Comments

Profound Medical

ニュース

最新ニュース Profound Medical (NASDAQ:PROF) 株価情報

ニュース

パートナーシップ

ベンジンガ・グローバル